Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007134,
umls-concept:C0017262,
umls-concept:C0021756,
umls-concept:C0032854,
umls-concept:C0034819,
umls-concept:C0332448,
umls-concept:C0334094,
umls-concept:C0870432,
umls-concept:C0871261,
umls-concept:C1171362,
umls-concept:C1515670,
umls-concept:C1555465,
umls-concept:C1561558,
umls-concept:C1704632,
umls-concept:C1705417,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
1993-4-7
|
pubmed:abstractText |
The fact that progressing tumors contain a significant infiltrate of T-cells brings into question the competency of the infiltrating T-lymphocytes (T-TIL). We have examined the role of the T-cell receptor/CD3 complex and/or the interleukin 2 receptor (IL2R) in responsiveness of T-cells that infiltrate human renal cell carcinoma. T-TIL display a poor proliferative response to interleukin 2 (IL2) alone, IL2 in combination with antibody to CD3, or mitogen stimulation. The proliferative unresponsiveness was not related to low expression of CD3 or IL2R beta as the percentage of T-cells expressing CD3 and IL2R beta were comparable in both T-TIL and peripheral blood T-cells obtained from the same patient. In contrast to the lack of proliferative activity, stimulation of T-TIL or peripheral blood lymphocytes with phytohemagglutinin or anti-CD3 resulted in comparable levels of both IL2 and gamma-interferon mRNA and protein expression. While levels of IL2R alpha were low in unstimulated T-TIL and peripheral blood lymphocytes, anti-CD3 antibody or IL2 were capable of inducing surface expression of this protein in both cell populations. IL2R alpha mRNA levels were comparable in T-cells from the tumor and peripheral blood although in some experiments both the percentage of IL2R alpha-positive cells and the density of surface expression per cell were reduced in T-TIL. This reduced IL2R alpha expression on T-TIL was not responsible for the proliferative unresponsiveness since T-TIL that expressed both IL2R alpha and/or IL2R beta still failed to respond to high doses of IL2. Thus T-TIL display a selective loss of response to at least two well defined extracellular stimuli. While T-TIL exhibit a poor proliferative response regardless of the form of stimulation these cells remain sensitive to both anti-CD3 and IL2 in terms of IL2 and gamma-interferon or IL2R alpha expression, respectively. The fact that proliferative unresponsiveness exists even though T-TIL can produce IL2 and express IL2R alpha/beta suggests that T-TIL have a selective loss of a common intracellular signaling pathway which is requisite to proliferation but not other aspects of response to antigenic stimulation.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1380-7
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8443817-Adult,
pubmed-meshheading:8443817-Aged,
pubmed-meshheading:8443817-Antigens, CD3,
pubmed-meshheading:8443817-Base Sequence,
pubmed-meshheading:8443817-Carcinoma, Renal Cell,
pubmed-meshheading:8443817-Humans,
pubmed-meshheading:8443817-Interferon-gamma,
pubmed-meshheading:8443817-Interleukin-2,
pubmed-meshheading:8443817-Kidney Neoplasms,
pubmed-meshheading:8443817-Lymphocyte Activation,
pubmed-meshheading:8443817-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:8443817-Middle Aged,
pubmed-meshheading:8443817-Molecular Sequence Data,
pubmed-meshheading:8443817-RNA, Messenger,
pubmed-meshheading:8443817-Receptors, Interleukin-2,
pubmed-meshheading:8443817-T-Lymphocytes
|
pubmed:year |
1993
|
pubmed:articleTitle |
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
|
pubmed:affiliation |
Department of Urology, Cleveland Clinic Foundation, Ohio 44195.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|